These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1658242)

  • 1. Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study.
    Yung WK; Prados M; Levin VA; Fetell MR; Bennett J; Mahaley MS; Salcman M; Etcubanas E
    J Clin Oncol; 1991 Nov; 9(11):1945-9. PubMed ID: 1658242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferon beta: a phase I-II trial in children with recurrent brain tumors.
    Allen J; Packer R; Bleyer A; Zeltzer P; Prados M; Nirenberg A
    J Clin Oncol; 1991 May; 9(5):783-8. PubMed ID: 2016620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous carboplatin for recurrent malignant glioma: a phase II study.
    Yung WK; Mechtler L; Gleason MJ
    J Clin Oncol; 1991 May; 9(5):860-4. PubMed ID: 1849986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group.
    Macdonald D; Cairncross G; Stewart D; Forsyth P; Sawka C; Wainman N; Eisenhauer E
    Ann Oncol; 1996 Feb; 7(2):205-7. PubMed ID: 8777179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irinotecan therapy in adults with recurrent or progressive malignant glioma.
    Friedman HS; Petros WP; Friedman AH; Schaaf LJ; Kerby T; Lawyer J; Parry M; Houghton PJ; Lovell S; Rasheed K; Cloughsey T; Stewart ES; Colvin OM; Provenzale JM; McLendon RE; Bigner DD; Cokgor I; Haglund M; Rich J; Ashley D; Malczyn J; Elfring GL; Miller LL
    J Clin Oncol; 1999 May; 17(5):1516-25. PubMed ID: 10334539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma.
    Reardon DA; Quinn JA; Vredenburgh J; Rich JN; Gururangan S; Badruddoja M; Herndon JE; Dowell JM; Friedman AH; Friedman HS
    Cancer; 2005 Jan; 103(2):329-38. PubMed ID: 15558802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Franceschi E; Cavallo G; Lonardi S; Magrini E; Tosoni A; Grosso D; Scopece L; Blatt V; Urbini B; Pession A; Tallini G; Crinò L; Brandes AA
    Br J Cancer; 2007 Apr; 96(7):1047-51. PubMed ID: 17353924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results.
    Galanis E; Buckner JC; Burch PA; Schaefer PL; Dinapoli RP; Novotny PJ; Scheithauer BW; Rowland KM; Vukov AM; Mailliard JA; Morton RF
    J Clin Oncol; 1998 Sep; 16(9):2953-8. PubMed ID: 9738563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of aziridinylbenzoquinone (AZQ: NSC-182986) in the treatment of malignant gliomas recurrent after radiation. Preliminary report.
    Decker DA; Al Sarraf M; Kresge C; Austin D; Wilner HI
    J Neurooncol; 1985; 3(1):19-21. PubMed ID: 2987424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).
    Poisson M; Péréon Y; Chiras J; Delattre JY
    J Neurooncol; 1991 Apr; 10(2):139-44. PubMed ID: 1654401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two studies evaluating irinotecan treatment for recurrent malignant glioma using an every-3-week regimen.
    Cloughesy TF; Filka E; Kuhn J; Nelson G; Kabbinavar F; Friedman H; Miller LL; Elfring GL
    Cancer; 2003 May; 97(9 Suppl):2381-6. PubMed ID: 12712460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study.
    Packer RJ; Prados M; Phillips P; Nicholson HS; Boyett JM; Goldwein J; Rorke LB; Needle MN; Sutton L; Zimmerman RA; Fitz CR; Vezina LG; Etcubanas E; Wallenberg JC; Reaman G; Wara W
    Cancer; 1996 May; 77(10):2150-6. PubMed ID: 8640684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
    Sipos L; Vitanovics D; Afra D
    Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
    Fine HA; Figg WD; Jaeckle K; Wen PY; Kyritsis AP; Loeffler JS; Levin VA; Black PM; Kaplan R; Pluda JM; Yung WK
    J Clin Oncol; 2000 Feb; 18(4):708-15. PubMed ID: 10673511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma.
    Clarke K; Basser RL; Underhill C; Mitchell P; Bartlett J; Cher L; Findlay M; Dalley D; Pell M; Byrne M; Geldard H; Hill JS; Maher D; Fox RM; Green MD; Kaye AH
    J Clin Oncol; 1999 Aug; 17(8):2579-84. PubMed ID: 10561325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent gliomas with eflornithine.
    Levin VA; Prados MD; Yung WK; Gleason MJ; Ictech S; Malec M
    J Natl Cancer Inst; 1992 Sep; 84(18):1432-7. PubMed ID: 1380989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
    Watanabe K; Kanaya H; Fujiyama Y; Kim P
    Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas.
    Fine HA; Wen PY; Robertson M; O'Neill A; Kowal J; Loeffler JS; Black PM
    Clin Cancer Res; 1997 Mar; 3(3):381-7. PubMed ID: 9815695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.
    Reardon DA; Quinn JA; Rich JN; Desjardins A; Vredenburgh J; Gururangan S; Sathornsumetee S; Badruddoja M; McLendon R; Provenzale J; Herndon JE; Dowell JM; Burkart JL; Newton HB; Friedman AH; Friedman HS
    Cancer; 2005 Oct; 104(7):1478-86. PubMed ID: 16088964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
    Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H
    Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.